Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Impact of Segmental Chromosome Aberrations in Non MYCN Amplified Neuroblastomas in Different Age Groups

NCT01589341 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01589341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01589341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Impact of Segmental Chromosome Aberrations in Non MYCN Amplified Neuroblastomas in Different Age Groups
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
Not reported
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma